BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 11733839)

  • 1. [Fraction of gemistocytic astrocytes and immunoexpression of p53 protein in astrocytomas grade II and III (WHO)].
    Martins DC; Stávale JN; Malheiros SM; Santiago LH; Roman LC; Aguiar KC
    Arq Neuropsiquiatr; 2001 Dec; 59(4):926-31. PubMed ID: 11733839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of gemistocytes in astrocytoma progression.
    Watanabe K; Tachibana O; Yonekawa Y; Kleihues P; Ohgaki H
    Lab Invest; 1997 Feb; 76(2):277-84. PubMed ID: 9042164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gemistocytes in astrocytomas: are they a significant prognostic factor?
    Martins DC; Malheiros SM; Santiago LH; Stávale JN
    J Neurooncol; 2006 Oct; 80(1):49-55. PubMed ID: 16645716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 and PTEN gene mutations in gemistocytic astrocytomas.
    Watanabe K; Peraud A; Gratas C; Wakai S; Kleihues P; Ohgaki H
    Acta Neuropathol; 1998 Jun; 95(6):559-64. PubMed ID: 9650746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic evidence of the neoplastic nature of gemistocytes in astrocytomas.
    Reis RM; Hara A; Kleihues P; Ohgaki H
    Acta Neuropathol; 2001 Nov; 102(5):422-5. PubMed ID: 11699553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gemistocytic astrocytomas: histomorphology, proliferative potential and genetic alterations--a study of 32 cases.
    Avninder S; Sharma MC; Deb P; Mehta VS; Karak AK; Mahapatra AK; Sarkar C
    J Neurooncol; 2006 Jun; 78(2):123-7. PubMed ID: 16614946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genotype-phenotype correlation in gemistocytic astrocytomas.
    Kösel S; Scheithauer BW; Graeber MB
    Neurosurgery; 2001 Jan; 48(1):187-93; discussion 193-4. PubMed ID: 11152345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microglia in gemistocytic astrocytomas.
    Geranmayeh F; Scheithauer BW; Spitzer C; Meyer FB; Svensson-Engwall AC; Graeber MB
    Neurosurgery; 2007 Jan; 60(1):159-66; discussion 166. PubMed ID: 17228265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-grade astrocytomas: the prognostic value of fibrillary, gemistocytic, and protoplasmic tumor histology.
    Babu R; Bagley JH; Park JG; Friedman AH; Adamson C
    J Neurosurg; 2013 Aug; 119(2):434-41. PubMed ID: 23662821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The significance of gemistocytes in astrocytoma.
    Yang HJ; Kim JE; Paek SH; Chi JG; Jung HW; Kim DG
    Acta Neurochir (Wien); 2003 Dec; 145(12):1097-103; discussion 1103. PubMed ID: 14663567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Definition and diagnostic implications of gemistocytic astrocytomas: a pathological perspective.
    Tihan T; Vohra P; Berger MS; Keles GE
    J Neurooncol; 2006 Jan; 76(2):175-83. PubMed ID: 16132490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gemistocytic astrocytomas: a reappraisal.
    Krouwer HG; Davis RL; Silver P; Prados M
    J Neurosurg; 1991 Mar; 74(3):399-406. PubMed ID: 1993905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53 protein expression in grade II astrocytomas: immunohistochemical study of 100 cases with long-term follow-up.
    Vital A; Loiseau H; Kantor G; Daucourt V; Chene G; Cohadon F; Rougier A; Rivel J; Vital C
    Pathol Res Pract; 1998; 194(12):831-6. PubMed ID: 9894248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression of P21 WAF1/CIP1 in human astrocytomas in correlating with P53, MDM2, and cellular proliferation index].
    Xu QZ; Liu F; Lu DH; Yu SZ; Yang H
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Aug; 23(4):341-5. PubMed ID: 12940073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic impact of TP53 mutations and P53 protein overexpression in supratentorial WHO grade II astrocytomas and oligoastrocytomas.
    Peraud A; Kreth FW; Wiestler OD; Kleihues P; Reulen HJ
    Clin Cancer Res; 2002 May; 8(5):1117-24. PubMed ID: 12006527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53 protein and epidermal growth factor receptor expression in human astrocytomas.
    Kordek R; Biernat W; Alwasiak J; Maculewicz R; Yanagihara R; Liberski PP
    J Neurooncol; 1995 Oct; 26(1):11-6. PubMed ID: 8583240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of p53 and CD31 in astrogliomas.
    Khattab AZ; Ahmed MI; Fouad MA; Essa WA
    Med Oncol; 2009; 26(1):86-92. PubMed ID: 18821037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High frequency of p53 protein accumulation without p53 gene mutation in human juvenile pilocytic, low grade and anaplastic astrocytomas.
    Lang FF; Miller DC; Pisharody S; Koslow M; Newcomb EW
    Oncogene; 1994 Mar; 9(3):949-54. PubMed ID: 8108140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Could changes in the regulation of the PI3K/PKB/Akt signaling pathway and cell cycle be involved in astrocytic tumor pathogenesis and progression?
    Hlobilkova A; Ehrmann J; Sedlakova E; Krejci V; Knizetova P; Fiuraskova M; Kala M; Kalita O; Kolar Z
    Neoplasma; 2007; 54(4):334-41. PubMed ID: 17822324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations of the RRAS and ERCC1 genes at 19q13 in gemistocytic astrocytomas.
    Ohta T; Kim YH; Oh JE; Satomi K; Nonoguchi N; Keyvani K; Pierscianek D; Sure U; Mittelbronn M; Paulus W; Vital A; Yokoo H; McDonald K; Kleihues P; Nazaret N; Barbet F; Lachuer J; Ohgaki H
    J Neuropathol Exp Neurol; 2014 Oct; 73(10):908-15. PubMed ID: 25192052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.